TURALIO® Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of ENLIVEN Phase 3 Trial.

TGCT, also referred to as pigmented villonodular synovitis (PVNS) or giant cell tumor of the tendon sheath (GCT-TS), is a rare, typically non-malignant tumor that can be locally aggressive.

BASKING RIDGE, N.J.-- (BUSINESS WIRE)--Jul 9, 2025--TURALIO® Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of ...

TURALIO® Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of ENLIVEN Phase 3 Trial ...

Precise segmentation of glioma subregions using multimodal MRI is crucial for accurate diagnosis and effective treatment. However, the absence of certain MRI modalities in clinical settings often ...

We’re not saying that atherosclerosis is a “blood vessel tumor.” But our data point to a possible interplay between genetic alterations and extensive cell division – something we typically associate ...

Inside the tumor: AI cracks five hidden cell types to stop cancer’s comeback Scientists have developed a new AI tool which could be integrated into cancer diagnostics to better inform treatment.

Breast tumor is one of the most common malignant cancers in women. Precise classification of breast tumors is pivotal for clinical treatment. Recently, deep learning, especially the Convolutional ...